Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Canadian Solar (CSIQ) PT Lowered to $15 at Citi
• Anthropic opens research preview for AI hardware standard